Personalized risk — stratified screening or abandoning it altogether? (Q63966623)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

title

Prostate cancer: Personalized risk - stratified screening or abandoning it altogether? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Sigrid V Carlsson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

2 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

140-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Expected population impacts of discontinued prostate-specific antigen screening

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRCLINONC.2016.11

10.1038/NRCLINONC.2016.11

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26831183 AND SRC:MED&resulttype=core&format=json

6 March 2020

1 reference